Clinical trials: Gastrostomy
Locally Advanced Head and Neck Carcinoma
Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy
This phase II trial studies Soylent in reducing gastrostomy tube rates in patients with head and neck cancer that has spread to nearby tissues or lymph nodes (locally advanced) who are undergoing chemoradiotherapy.
- Trial name
- NCT07242365
- Testing
- Soylent Graham Dietary Supplement, Laboratory Biomarker Analysis, Quality-of-Life Assessment
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Jonsson Comprehensive Cancer Center
Atrial Fibrillation, Fragility
EdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllation
The goal of this interventional study is to describe the use of Edoxaban via PEG in patients with an indication to anticoagulation therapy.
- Trial name
- ORIGAMI II (NCT06285942)
- Testing
- Edoxaban, No Edoxaban
- Where
- 3 sites in Italy
- Volunteers
- 168 people
- Sponsor
- Azienda Ospedaliero Universitaria Maggiore della Carita